Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark it read-only, open-world, and idempotent; the description adds substantial behavioral detail: cascading internal lookups, explicit `figi_candidates` on ambiguity, explicit `unresolved` listing, and graceful degradation when LEI/FIGI sources are unavailable. This is far beyond what annotations provide.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but densely informative, with a clear front-loaded purpose and concrete examples. Some parentheticals and emphasized phrases add length, but the detail is generally purposeful for a tool with this much scope.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Without an output schema, the description must convey return behaviors, and it does: mentions `figi_candidates`, `unresolved`, source labels, and degradation. It is complete for decision-making, though a structured response shape or explicit distinction from sibling entity tools would push it further.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but the description adds meaning beyond the schema: it explains accepted input types (ticker, CIK, ISIN, name), warns about passing only the entity name rather than the full noun phrase, and clarifies non-equity/instrument edge cases. This complements the schema's own value description.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb ('resolve') and resource ('user-spoken NAME to canonical/official identifiers'), with concrete user phrasings and two supported types (company, drug). It clearly differentiates itself from sibling tools by emphasizing it produces IDs that other tools require as input.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit trigger guidance ('Use FIRST whenever you have a name but need an ID') and context on when resolution may return multiple candidates or fail gracefully. Does not explicitly contrast with sibling tools like entity_profile or compare_entities, so exclusions are absent.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.1/5.0
Disambiguation1/5

The toolset is overwhelmingly fragmented: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-identical entry points; polymarket_edges, polymarket_arbitrage, and polymarket_fill_risk heavily overlap; and ai_visibility_check vs scan_competitor_ai_presence cover the same task. The five actual Wiktionary tools are distinct but are lost among dozens of unrelated research and prediction-market tools, making selection highly ambiguous.

Naming Consistency3/5

All names use snake_case and several logical prefixes (ask_pipeworx, polymarket_, pipeworx_) create local patterns. However, the naming mixes noun-style commands (definition, etymology, pronunciations, summary) with verb-style commands (search, remember, forget, validate_claim), and no consistent verb_noun convention carries across the whole set.

Tool Count1/5

36 tools is already heavy, but the deeper problem is that only 5 tools actually belong to a Wiktionary server while 31 tools serve unrelated Pipeworx, Polymarket, memory, and marketing-audit functions. The count is wildly inappropriate for the declared server purpose.

Completeness2/5

The Wiktionary-relevant tools cover basic word lookup—search, summary, definition, etymology, pronunciations—but omit common dictionary operations like translations, usage examples, inflected forms, or random entries. The non-Wiktionary majority does not fill these gaps; it just makes the surface area incoherent and hard to reason about.